Symmetry Partners, LLC Incyte Corp Transaction History

Symmetry Partners, LLC

  • $422 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021
SELL
$76.02 - $100.5 $194,307 - $256,878
-2,556 Closed
0 $0
Q4 2020

Feb 18, 2021
SELL
$80.74 - $97.7 $161 - $195
-2 Reduced 0.08%
2,556 $222,000
Q3 2020

Nov 03, 2020
BUY
$85.07 - $109.69 $217,609 - $280,587
2,558 New
2,558 $230,000

Others Institutions Holding INCY

# of Institutions
657
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Symmetry Partners, LLC Portfolio

Follow Symmetry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email